210
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Lipoprotein profile, plasma Ischemia Modified Albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study

, , , , , , , , , , , & show all
Pages 201-208 | Received 04 Aug 2009, Accepted 14 Jan 2010, Published online: 16 Mar 2010

References

  • Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab 1999;3:199–211.
  • Kwiterovich PO Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 2002;90:30i–47i.
  • Tsimihodimos V, Gazi I, Kostara C, Tselepis AD, Elisaf M. Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles. Lipids 2007;42:403–9.
  • Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299–308.
  • Van Oostrom AJ, Castro Cabezas M, Ribalta J, Masana L, Twickler TB, Remijnse TA, Erkelens DW. Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet. Eur J Clin Invest 2000;30:964–71.
  • Chan BM, Dodsworth N, Woodrow J, Tucker A, Harris R. Site specific N-terminal autodegradaton of human serum albumin. Eur J Biochem 1995;227:524–8.
  • Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004;50:2190–3.
  • Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985–91.
  • Consuegra-Sanchez L, Bouzas-Mosquera A, Sinha MK, Collinson PO, Gaze DC, Kaski JC. Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels 2008;23:174–80.
  • Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002;48:1097–100.
  • Gan SI, Edwards AL, Symonds CJ, Beck PL. Hypertriglyceridemia-induced pancreatitis: a case-based review. World J Gastroenterol 2006;12:7197–202.
  • Shaw DI, Tierney AC, McCarthy S, Upritchard J, Vermunt S, Gulseth HL, Drevon CA, Blaak EE, Saris WH, Karlström B, Helal O, Defoort C, Gallego R, López-Miranda J, Siedlecka D, Malczewska-Malec M, Roche HM, Lovegrove JA. LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br J Nutr 2009; 101:750–9.
  • Swinkels DW, Heidi LM, Hak-Lemmers HL, Demacker PN. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lip Res 1987;28:1233–9.
  • Bar-Or D, Lan E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia – a preliminary report. J Emerg Med 2000; 19:311–5.
  • Wallin B, Rosengren B, Shertzer HG, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for the evaluation of antioxidants. Anal Biochem 1993;208:10–5.
  • Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of the ‘antioxidant power’: the FRAP assay. Anal Biochem 1996;239:70–6.
  • Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007;133:496–506.
  • Gannon MC, Nuttall FQ, Westphal SA, Neil BJ, Seaquist ER. Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care 1989;12:544–52.
  • Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Hoursalas IS, Manolis A, Cokkinos DV. Postprandial lipemia in menopausal women with metabolic syndrome. Maturitas 2006;55:19–26.
  • Brynes AE, Edwards CM, Ghatei MA, Bloom SR, Frost GS. Men at increased risk of coronary heart disease are not different from age- and weight-matched healthy controls in their postprandial triglyceride, nonesterified fatty acid, or incretin responses to sucrose. Metabolism 2002;51:195–200
  • Ashida Y, Takagi A, Ikeda Y. Improved method for non-denaturing polyacrylamide gradient gel electrophoresis for detection of small sized LDL produced during postprandial hypertriglyceridaemia. Scand J Clin Lab Invest 1999; 59:663–70.
  • Pirro M, Lupattelli G, Siepi D, Palumbo B, Roscini AR, Marchesi S, Schillaci G, Mannarino E. Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women. Metabolism 2001; 50:330–4.
  • Attia N, Durlach V, Paul JL, Soni T, Betoulle D, Girard Globa A. Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects. Atherosclerosis 1995;113:197–209.
  • Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J Intern Med 1995;237:5–12.
  • Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH. Lewis GF. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 1999;103:1191–9.
  • Callow J, Summers LK, Bradshaw H, Frayn KN. Changes in LDL particle composition after the consumption of meals containing different amounts and types of fat. Am J Clin Nutr 2002;76:345–50.
  • Heath RB, Karpe F, Milne RW, Burdge GC, Wootton SA, Frayn KN. Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J Lip Res 2003;44:2065–72.
  • Rizzo M, Taylor JM, Barbagallo CM, Berneis K, Blanche PJ, Krauss RM. Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler Thromb Vasc Biol 2004; 24:141–6.
  • Rouhani N, Young E, Chatterjee C, Sparks DL. HDL composition regulates displacement of cell surface-bound hepatic lipase. Lipids 2008;43:793–804.
  • Chung BH, Cho BH, Liang P, Doran S, Osterlund L, Oster RA, Darnell B, Franklin F. Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans. Am J Clin Nutr 2004;80:1145–58.
  • Roy D, Quiles J, Caze D, Collinson PO, Kaski J, Baxter C. Role of reactive oxygen species in the formation of the novel diagnostic marker ischemia modified albumin. Heart 2006; 92:113–4.
  • Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666–71.
  • Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114: 1752–61.
  • Bhagavan NV, Ha JS, Park JH, Honda SA, Rios CN, Sugiyama C, Fujitani GK, Takeuchi IK, Ha CE. Utility of serum fatty acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem 2009;55:1588–90.
  • Tribble D, Holl I, Wood P, Krauss R. Variation in oxidative susceptibility among six LDL subfractions of differing particle size. Atherosclerosis 1992;93:189–99.
  • Minihane AM, Khan S, Talmud PJ, Williams DL, Wright JW, Murphy MC, Griffin BA, Williams CM. Lack of association between lipaemia and central adiposity in subjects with an atherogenic lipoprotein phenotype (ALP). Int J Obes Relat Metab Disord 2000;24:1097–10.
  • Steiner G. Hyperinsulinaemia and hypertriglyceridaemia. J Intern Med Suppl 1994;736:23–6.
  • Manco M, Calvani M, Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 2004;6:402–13.
  • Carey DG. Abdominal obesity. Curr Opin Lipidol 1998; 9:35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.